ShanX Medtech B.V., a spin-off of Eindhoven University of Technology (TU/e), has secured a total of €24 million in funding to accelerate the development of its ultra-rapid antimicrobial susceptibility ...

The funding will support final development, clinical validation, regulatory approval, and commercial launch of an ultra-rapid AST platform.

Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...

Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at ...

Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory ...

A new study offers a solution to infections with the pathogenic fungus Candida auris by taking a new precision diagnostic ...

The approval significantly strengthens Delhi’s ability to diagnose multidrug-resistant (MDR-TB) and drug-resistant ...

ALBUQUERQUE, N.M. (KRQE) — NASA’s “VIPER” mission to map water concentrations on the moon left its rover spinning at Sandia National Laboratories. Scientists put the “VIPER” rover to the test in a ...

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Colleen Hagerty Colleen Hagerty is a writer focused on emergency preparedness.

Robotic hospital assistants that can autonomously collect blood from patients and transport samples from the ward to the testing lab, are being put through their paces at Fujita Health University ...